Jump to main content
Jump to site search

Issue 12, 2016
Previous Article Next Article

Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stability

Author affiliations

Abstract

The discontinuation of PAR-1 antagonist RWJ-58259 beyond use as a biological probe is most likely due to it's short half-life in vivo. However, retention of significant in vivo activity beyond the point where most of the RWJ-58259 had been consumed implies the generation of an active metabolite. Herein we describe the biological activity of a predicted metabolite of RWJ-58259 and the synthesis of analogues designed to enhance the metabolic stability of RWJ-58259.

Graphical abstract: Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stability

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 10 Feb 2016, accepted on 25 Feb 2016 and first published on 25 Feb 2016


Article type: Communication
DOI: 10.1039/C6OB00332J
Citation: Org. Biomol. Chem., 2016,14, 3198-3201
  •   Request permissions

    Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stability

    E. Robinson, E. Knight, N. Smoktunowicz, R. C. Chambers, G. G. Inglis, V. Chudasama and S. Caddick, Org. Biomol. Chem., 2016, 14, 3198
    DOI: 10.1039/C6OB00332J

Search articles by author